NO20012307L - Trypsinsubstrat og diagnostisk innretning, samt fremgangsmåte for bruk av denne - Google Patents

Trypsinsubstrat og diagnostisk innretning, samt fremgangsmåte for bruk av denne

Info

Publication number
NO20012307L
NO20012307L NO20012307A NO20012307A NO20012307L NO 20012307 L NO20012307 L NO 20012307L NO 20012307 A NO20012307 A NO 20012307A NO 20012307 A NO20012307 A NO 20012307A NO 20012307 L NO20012307 L NO 20012307L
Authority
NO
Norway
Prior art keywords
methods
well
diagnostic device
pressure substrate
substrate
Prior art date
Application number
NO20012307A
Other languages
English (en)
Norwegian (no)
Other versions
NO20012307D0 (no
Inventor
Paul F Corey
Steven W Felman
Gary E Rehm
Michael J Pugia
Original Assignee
Bayer Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Ag filed Critical Bayer Ag
Publication of NO20012307D0 publication Critical patent/NO20012307D0/no
Publication of NO20012307L publication Critical patent/NO20012307L/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C279/00Derivatives of guanidine, i.e. compounds containing the group, the singly-bound nitrogen atoms not being part of nitro or nitroso groups
    • C07C279/30Derivatives of guanidine, i.e. compounds containing the group, the singly-bound nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of guanidine groups bound to nitro or nitroso groups
    • C07C279/32N-nitroguanidines
    • C07C279/36Substituted N-nitroguanidines
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D207/00Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/30Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
    • C07D207/34Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D207/36Oxygen or sulfur atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D209/00Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04Indoles; Hydrogenated indoles
    • C07D209/30Indoles; Hydrogenated indoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to carbon atoms of the hetero ring
    • C07D209/32Oxygen atoms
    • C07D209/36Oxygen atoms in position 3, e.g. adrenochrome
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D277/00Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D277/32Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D277/34Oxygen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D311/00Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/04Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
    • C07D311/06Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 2
    • C07D311/08Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 2 not hydrogenated in the hetero ring
    • C07D311/16Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 2 not hydrogenated in the hetero ring substituted in position 7
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/34Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving hydrolase
    • C12Q1/37Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving hydrolase involving peptidase or proteinase
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07BGENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00Indexing scheme relating to specific properties of organic compounds
    • C07B2200/07Optical isomers
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02PCLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00Technologies relating to chemical industry
    • Y02P20/50Improvements relating to the production of bulk chemicals
    • Y02P20/55Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Zoology (AREA)
  • Engineering & Computer Science (AREA)
  • Wood Science & Technology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Genetics & Genomics (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Physics & Mathematics (AREA)
  • Biochemistry (AREA)
  • Analytical Chemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Biotechnology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Apparatus Associated With Microorganisms And Enzymes (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
  • Pyrane Compounds (AREA)
  • Pyrrole Compounds (AREA)
  • Indole Compounds (AREA)
  • Peptides Or Proteins (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
NO20012307A 2000-05-15 2001-05-10 Trypsinsubstrat og diagnostisk innretning, samt fremgangsmåte for bruk av denne NO20012307L (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US20399900P 2000-05-15 2000-05-15

Publications (2)

Publication Number Publication Date
NO20012307D0 NO20012307D0 (no) 2001-05-10
NO20012307L true NO20012307L (no) 2001-11-16

Family

ID=22756189

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20012307A NO20012307L (no) 2000-05-15 2001-05-10 Trypsinsubstrat og diagnostisk innretning, samt fremgangsmåte for bruk av denne

Country Status (9)

Country Link
US (1) US6770764B2 (ja)
EP (1) EP1157984A3 (ja)
JP (1) JP5016752B2 (ja)
AU (1) AU785019B2 (ja)
CA (1) CA2334827A1 (ja)
IL (1) IL140993A0 (ja)
NO (1) NO20012307L (ja)
NZ (1) NZ509863A (ja)
ZA (1) ZA200102450B (ja)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1675874A1 (en) * 2003-10-16 2006-07-05 Bayer HealthCare LLC Monoclonal antibodies for detection of urinary trypsin inhibitors
GB2435510A (en) * 2006-02-23 2007-08-29 Mologic Ltd Enzyme detection product and methods
WO2008154238A1 (en) * 2007-06-06 2008-12-18 Siemens Healthcare Diagnostics Inc. Predictive diagnostics for kidney disease
US20150369747A1 (en) 2011-07-15 2015-12-24 Siemens Healthcare Diagnostics Inc. Device and method for detection of humidity-compromised urine test strips
AU2010206939B2 (en) 2009-01-26 2014-08-21 Siemens Healthcare Diagnostics Inc. Device and method for detection of humidity-compromised urine test strips
CN115872919A (zh) * 2022-12-28 2023-03-31 吉林医药学院 一种3-(n-对甲苯磺酰基-l-丙氨酰氧基)吲哚的转晶方法

Family Cites Families (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3552928A (en) 1967-07-19 1971-01-05 Miles Lab Whole blood separation means and test system using same
DE2118455B1 (de) 1971-04-16 1972-09-21 Boehringer Mannheim Gmbh Teststreifen
DE2158124C3 (de) 1971-11-24 1975-03-13 Boehringer Mannheim Gmbh, 6800 Mannheim Verwendung von Polyamidvlies oder -filz als saugfähiger Träger für diagnostische Mittel
US4128540A (en) * 1972-05-25 1978-12-05 Parke, Davis & Company Pyroglutamyl-histidyl-tryptophanyl-seryl-tyrosyl hydrazides
US3846247A (en) 1972-09-27 1974-11-05 Warner Lambert Co Moisture barrier
US4046513A (en) 1976-06-30 1977-09-06 Miles Laboratories, Inc. Printed reagent test devices and method of making same
US4046514A (en) 1976-11-24 1977-09-06 Miles Laboratories, Inc. Test device and method for determining a component in a sample
HU181009B (en) * 1980-01-18 1983-05-30 Richter Gedeon Vegyeszet Process for preparing angiotensin-ii analogues with antagonictic activity containing in position 1 sarcosyl,hydroxyacetyl or l-alpha-aminoxy-propionyl group and in positiona 8 esteric group
DE3017721A1 (de) 1980-05-09 1981-11-26 Boehringer Mannheim Gmbh, 6800 Mannheim Mittel zum nachweis esterolytischer und/oder proteolytischer enzyme und dafuer geeignete substrate
US4657855A (en) 1984-04-06 1987-04-14 Miles Laboratories, Inc. Composition and test device for determining the presence of leukocytes, esterase and protease in a test sample
US4704460A (en) 1984-04-06 1987-11-03 Miles Laboratories, Inc. Novel compounds for detecting the presence of hydrolytic analytes in a test sample
US4774340A (en) 1984-04-06 1988-09-27 Miles Inc. Method for preparing 3-hydroxy pyrroles and esters thereof
US4645842A (en) 1984-04-06 1987-02-24 Miles Laboratories, Inc. Pyrrole compounds for detecting the presence of hydrolytic analytes
US4717658A (en) 1985-12-03 1988-01-05 Miles Inc. Gram negative bacteria screening method with horseshoe crab amebocyte lysate (LAL)
US5175089A (en) * 1988-07-15 1992-12-29 The Trustees Of Columbia University In The City Of New York Method for monitoring periodontal disease by monitoring endotoxins and inflammatory agents
JPH0578391A (ja) * 1991-09-12 1993-03-30 Hitachi Chem Co Ltd ペプチドおよびその塩
JPH05140195A (ja) * 1991-11-12 1993-06-08 Hitachi Chem Co Ltd ペプチドおよびその塩
JPH06228189A (ja) * 1993-01-06 1994-08-16 Fuji Photo Film Co Ltd ペプチド誘導体およびその用途
US5422341A (en) * 1993-08-06 1995-06-06 Ohmeda Pharmaceutical Products Division Inc. Motilin-like polypeptides with gastrointestinal motor stimulating activity
US5750405A (en) 1996-03-01 1998-05-12 Bayer Corporation Method for the detection for protein
KR100356956B1 (ko) 1996-03-11 2003-03-15 베이어 코오포레이숀 사람비쿠닌
KR980010425A (ko) * 1996-07-30 1998-04-30 안홍원 뇨중 백혈구 및 단백질 분해 효소 검출을 위한 조성물 및 측정기구
JP3626982B2 (ja) 1997-08-29 2005-03-09 アークレイ株式会社 タンパク質分解酵素阻害物質の測定方法およびそれに用いる測定キット

Also Published As

Publication number Publication date
US20020004219A1 (en) 2002-01-10
EP1157984A3 (en) 2004-01-02
NO20012307D0 (no) 2001-05-10
JP2002069055A (ja) 2002-03-08
NZ509863A (en) 2002-09-27
AU785019B2 (en) 2006-08-24
EP1157984A2 (en) 2001-11-28
ZA200102450B (en) 2001-09-28
JP5016752B2 (ja) 2012-09-05
US6770764B2 (en) 2004-08-03
AU2121301A (en) 2001-11-22
CA2334827A1 (en) 2001-11-15
IL140993A0 (en) 2002-02-10

Similar Documents

Publication Publication Date Title
GB2418258B (en) Analyte testing device
DK1458299T3 (da) Indretning til osteosyntese
EP1669720A4 (en) NAVIGATION DEVICE AND METHOD AND PROGRAM THEREOF
NO20041512L (no) Drivanordning, fremvisningsinnretning som benytter drivanordningen, og fremgangsmate for drift av denne.
NO20044366L (no) Nedihulls provetakningsanordning samt fremgangsmate for anvendelse av denne
ITTO20020033A0 (it) Dispositivo elettro-luminescente.
DK1354224T3 (da) Sensorindretning, fremgangsmåde til dens fremstilling og anvendelse
AU2003237344A1 (en) Testing device
ES1052161Y (es) Dispositivo homogeneizador batidor perfeccionado.
AU2003289853A8 (en) Methods, device and instrument for detection of analytes
NO20031465D0 (no) System for måling av forskyvning, samt fremgangsmåte
ITTO20020003A0 (it) Dispositivo di verifica per veicolo.
BR0113254B1 (pt) dispositivo emagrecedor.
ITMI20031655A1 (it) Dispositivo visualizzante.
NO20012307L (no) Trypsinsubstrat og diagnostisk innretning, samt fremgangsmåte for bruk av denne
BR0116998B1 (pt) dispositivo osteossintético.
MXPA03006284A (es) Dispositivo de ensayo.
ITTO20010771A0 (it) Metodo di autenticazione mediante dispositivo di memorizzazione.
GB0223632D0 (en) Semiconductor testing instrument
ITTO20010432A0 (it) Dispositivo e metodo per la rilevazione di forme, in particolare modelli di calzatura.
NO20011246D0 (no) FastlÕsningsanordning og nedføringsinnretning for denne, samt system for fastlÕsningsanordningen og nedføringsinnretningen
DE50308314D1 (de) Druckdichte Kontakteinrichtung
FR2844183B3 (fr) Dispositif de massage.
ITTO20020264A0 (it) Dispositivo acquastop perfezionato.
ITTO20030081A1 (it) Dispositivo di misura.

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application